The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials
Crossref DOI link: https://doi.org/10.1186/s12879-016-1823-5
Published Online: 2016-09-15
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Fang
Wang, Hong-Mei
Wang, Tiansheng
Zhang, Ya-Mei
Zhu, Xi
Funding for this research was provided by:
National Natural Science Foundation of China (81372043)
Beijing Natural Science Foundation (7162199)